Caliber Imaging & Diagnostics, Inc., commonly referred to as Caliber ID, is a leading innovator in the field of medical imaging and diagnostics, headquartered in the United States. Founded in 2008, the company has established itself as a key player in the dermatology and oncology sectors, focusing on advanced imaging technologies that enhance disease detection and patient care. Caliber ID's core offerings include state-of-the-art imaging systems and diagnostic tools that utilise proprietary algorithms for improved accuracy and efficiency. Their unique approach to integrating artificial intelligence with imaging solutions sets them apart in a competitive market. With a commitment to advancing healthcare, Caliber ID has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to early disease detection.
How does Caliber Imaging & Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Caliber Imaging & Diagnostics, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Caliber Imaging & Diagnostics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Caliber Imaging & Diagnostics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of climate action, many companies are increasingly adopting Science-Based Targets Initiative (SBTi) goals and participating in initiatives like CDP and RE100 to enhance their sustainability profiles. However, without specific emissions data or commitments, it is unclear how Caliber Imaging & Diagnostics aligns with these industry trends.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Caliber Imaging & Diagnostics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
